丹红注射液治疗急性脑梗死的临床疗效分析

目的:探讨丹红注射液治疗急性脑梗死的临床疗效。方法:选择2016年1月至2017年6月来我院进行治疗急性脑梗死疾病患者70例作为本研究的对象,采用随机数字表法均分为研究组和对照组。对照组采用常规抗血小板聚集、降低颅内压、营养脑细胞等治疗,研究组在对照组的基础上采用丹红注射液治疗,对比两组患者的疗效、治疗前后的神经功能缺损评分、日常生活活动能力评分、全血黏度和红细胞比积的变化。结果:治疗后,对照组患者的治疗有效率(82.86%)显著低于研究组(94.29%)(P0.05),研究组患者日常生活活动能力评分显著高于对照组(P0.05),神经功能缺损评分、全血黏度、红细胞比积均显著低于对照组(P0.05)。结论:丹红注射液用于治疗急性脑梗死可显著提高其临床疗效,明显提高患者日常生活能力,改善神经功能和血液流变学。

Clinical Efficacy of Danhong Injection in the Treatment of Acute Cerebral Infarction

ABSTRACT Objective: To investigate the clinical efficacy of danhong injection in the treatment of acute cerebral infarction. Methods: 70 cases of patients with acute cerebral infarction admitted in our hospital from January 2016 to June 2016 were selected as the research object and randomly divided into the research group and the control group with 35 cases in each group according to the digital random table method. The control group was given conventional treatment, including platelet aggregation and reduce intracranial pressure, nutri- tion brain cells, etc, while the research group was given danhong injection on the basis of control group, the curative effect, changes of nerve function defect grade, daily life activities ability score, whole blood viscosity and red blood cells were compared between two groups of patients before and after treatment. Results: After treatment, the treatment effective rate of control group was 82.86 %, which was significantly lower than that of the research group(94.29 %, P<0.05). The daily life activity score of research group was higher than that of the control group(P>0.05). while the neurological impairment score, blood viscosity and erythrocyte ratio were obviously lower than those of the control group(P<0.05). Conclusion: Danhong injection could remarkably enhance the clinical efficacy in the treatment of acute cerebral infarction, it could obviously enhance the daily living ability, improve the blood rheological index and nerve function.